期刊文献+

联合尿N-乙酰-β-D-氨基葡萄糖苷酶与尿/血渗透压比测定在糖尿病肾病早期诊断中的价值 被引量:5

The Value of Combined with Urinary N-acetyl-β-D-glucosaminidase and Urine to Blood Osmolality Ratio in Early Diagnosis of Diabetic Nephropathy
下载PDF
导出
摘要 目的:评价联合尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)与尿/血渗透压比测定在糖尿病肾病早期诊断中的价值。方法:2型糖尿病患者150例,按尿白蛋白排泄率(UAER)分为A组65例(UAER<20μg/min),B组54例(20μg/min≤UAER<200μg/min),C组31例(UAER≥200μg/min),正常对照组30例,测定血、尿渗透压、尿/血渗比及尿NAG,并比较。结果:(1)相关分析显示,尿NAG与病程、UAER、BUN、年龄呈显著正相关(r=0.296、0.424、0.247、0.266,P<0.01),与Hb A1c、尿糖、血肌酐亦呈正相关(r=0.217、0.205、0.245,P<0.05);尿/血渗比与病程、UAER、血肌酐、年龄呈显著负相关(r=-0.259、-0.371、-0.252、-0.282,P<0.01),与Hb A1c呈负相关(r=-0.227,P<0.05),与GFR呈正相关(r=0.200,P<0.05)。(2)A、B、C各组与对照组尿NAG及尿/血渗比差异均存在统计学意义(P<0.05)。结论:联合尿NAG与尿/血渗比测定可全面评估肾小管功能,有助于糖尿病肾病的早期诊断。 Objective: To evaluate the value of combined with urine to blood osmolality ratio and urinary N-acetyl- β -D-glocosaminidase ( NAG ) in early diagnose of diabetic nephropathy. Method: A total of 150 patients with type 2 diabetes mellitus were divided into three groups including group A ( UAER〈20 μ g/min, 65 cases ), group B ( 20 μ g/min ≤ UAER〈200 μg/min, 54 cases ), and group C ( UAER ≥ 200 μg/min, 31 cases ) . 30 healthy subjects were enrolled as the control group. The blood-urinary osmolality and urinary NAG were determined, which were compared between the three groups. Result: ( 1 ) Correlation analysis showed that urinary NAG was positively correlated with course, UAER, BUN, age (r=0.296, 0.424, 0.247, 0.266, P〈0.01 ), HbAlc, urine-glucose, and creatinine (r=0.217, 0.205, 0.245, P〈0.05 ) . Urine to blood osmolality ratio was negatively correlated with disease course, UAER, serum creatinine, age (r=-0.259, -0.371, -0.252, -0.282, P〈0.01 ), HbAlc ( r=-0.227, P〈0.05 ), but positively GFR ( r=0.200, P〈0.05 ) . ( 2 ) There were significant differences between the three groups in urinary NAG and urine to blood osmolality ratio ( P〈0.05 ) . Conclusion: Urinary NAG combined with urine to blood osmolality ratio contribute to complete assessment the renal tubular function, and is conducive to the early diagnosis of diabetic nephropathy.
出处 《中国医学创新》 CAS 2015年第25期4-7,共4页 Medical Innovation of China
基金 包头市医药卫生科技计划项目(BK2014100)
关键词 糖尿病肾病 N-乙酰-Β-D-氨基葡萄糖苷酶 尿/血渗透压比值 Diabetic nephropathy N-acetyl- β -D-glocosaminidase Urinary to blood osmolality ratio
  • 相关文献

参考文献16

二级参考文献124

  • 1辛岗,王芳,王梅,焦莉莉,徐国宾,王海燕.点时间尿蛋白与尿肌酐比值检测的临床应用评价[J].中华肾脏病杂志,2005,21(5):247-250. 被引量:45
  • 2倪方荣.微量尿蛋白检测技术对早期糖尿病肾病监控的价值[J].解放军保健医学杂志,2005,7(2):122-123. 被引量:7
  • 3王勇.肾病患者血清及尿液渗透压的临床分析[J].河北医药,2005,27(7):531-531. 被引量:3
  • 4闻平,陈蕾,郭月芳,周春红.晨尿尿蛋白/尿渗透压比值测定的临床应用评价[J].国际检验医学杂志,2006,27(9):777-778. 被引量:11
  • 5梁子钧 戴稼禾 编著.体液渗透压测定在医学中的应用[M].北京:人民卫生出版社,1988.420.
  • 6Buter H, Hemmelder MH, Navis G, et al. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant, 1998,13:1682-1685.
  • 7Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA, 2002,288:2421-2431.
  • 8Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med, 2002,347:1256-1261.
  • 9Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol, 2006, 17: 2974-2984.
  • 10Donadelli R, Abbate M, Zanchi C, et al. Protein traffic activates NF-kappaB gene signaling and promotes MCP-Idependent interstitial inflammation. Am J Kidney Dis, 2000, 36:1226-1241.

共引文献243

同被引文献76

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部